Hanson Kristopher 4
4 · MapLight Therapeutics, Inc. · Filed Apr 17, 2026
Research Summary
AI-generated summary of this filing
MapLight (MPLT) General Counsel Kristopher Hanson Sells Shares
What Happened
Kristopher Hanson, General Counsel of MapLight Therapeutics (MPLT), reported open-market sales totaling 1,827 shares for aggregate proceeds of approximately $49,134. The transactions were: 1,529 shares on 2026-04-15 at $26.80 ($40,977); 73 shares on 2026-04-16 at $27.01 ($1,972); and 225 shares on 2026-04-16 at $27.49 ($6,185). According to the filing footnote, at least some of the sales were made to satisfy statutory tax-withholding obligations in connection with RSU vesting (routine, not necessarily a sentiment signal).
Key Details
- Transaction dates and prices: 2026-04-15 — 1,529 @ $26.80; 2026-04-16 — 73 @ $27.01 and 225 @ $27.49.
- Total shares sold: 1,827; total reported proceeds: ~$49,134.
- Shares owned after transaction: not specified in the provided summary of the filing.
- Notable footnotes: F1 indicates sales to cover tax withholding for vested RSUs; F2/F4/F5 note reported prices are weighted averages with share-price ranges and the reporting person will provide per-price details on request; F3 notes 410 shares were acquired under the issuer’s employee stock purchase plan on 2026-03-31.
- Filing timeliness: Form 4 was filed 2026-04-17 (reporting period starts 2026-04-15), within the normal 2-business-day reporting window.
Context
These were sales (S) and appear at least partly routine tax-withholding dispositions tied to RSU vesting. For retail investors, purchases tend to be more informative about insider conviction; routine withholding sales are common and do not necessarily indicate a change in insider sentiment.
Insider Transaction Report
- Sale
Voting Common Stock
[F1][F2][F3]2026-04-15$26.80/sh−1,529$40,977→ 190,463 total - Sale
Voting Common Stock
[F1][F4]2026-04-16$27.01/sh−73$1,972→ 190,390 total - Sale
Voting Common Stock
[F1][F5]2026-04-16$27.49/sh−225$6,185→ 190,165 total
Footnotes (5)
- [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.33 to $27.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (5).
- [F3]Includes 410 shares acquired under the Issuer's stock purchase plan on March 31, 2026.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2201 to $27.2197 inclusive.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.9898 inclusive.